Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB-TNXA hybrids in apparent large-scale gene conversions

Human Molecular Genetics

Volumn 11, Issue 21, 2002, Pages 2581-2590

  Koppens, Paul F J ^a,b   Hoogenboezem, Theo ^a   Degenhart, Herman J ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A; DNA; STEROID 21 MONOOXYGENASE; TENASCIN;

ARTICLE; CHROMOSOME ABERRATION; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CROSSING OVER; DNA FLANKING REGION; DNA HYBRIDIZATION; EHLERS DANLOS SYNDROME; GENE CONVERSION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE STRUCTURE; HAPLOTYPE; HETEROZYGOTE; HUMAN; INBORN ERROR OF METABOLISM; MAJOR HISTOCOMPATIBILITY COMPLEX; MEIOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOGENE; TANDEM REPEAT;

EID: 0036799145     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.21.2581     Document Type: Article

References (48)

1. Strachan, T. (1990) Molecular pathology of congenital adrenal hyperplasia. Clin. Endocrinol., 32, 373-393.
2. New, M.I. (1998) Diagnosis and management of congenital adrenal hyperplasia Annu. Rev. Med., 49, 311-328.
3. Morel, Y. and Miller, W.L. (1991) Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv. Hum. Genet., 20, 1-68.
4. Wedell, A. (1998) Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment. Acta Paediatr, 87, 159-164.
5. White, P.C. and Speiser, P.W.(2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. Rev., 21, 245-291.
6. White, P.C., Grossberger, D., Onufer, B.J., Chaplin, D.D., New, M.I., Dupont, B. and Strominger, J.L. (1985) Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc. Natl Acad. Sci. USA, 82, 1089-1093.
7. Carroll, M.C., Palsdottir, A., Belt, K.T. and Porter, R.R. (1985) Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region. EMBO J., 4, 2547-2552.
8. Sargent, C.A., Anderson, M.J., Hsieh, S.L., Kendall, E., Gomez-Escobar, N. and Campbell, R.D. (1994) Characterisation of the novel gene G11 lying adjacent to the complement C4A gene in the human major histocompatibility complex. Hum. Mol. Genet., 3, 481-488.
9. Shen, L., Wu, L.C., Sanlioglu, S., Chen, R., Mendoza, A.R., Dangel, A.W., Carroll, M.C., Zipf, W.B. and Yu, C.Y. (1994) Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. J. Biol. Chem., 269, 8466-8476.
10. Gomez-Escobar, N., Chou, C.F., Lin, W.W., Hsieh, S.L. and Campbell, R.D. (1998) The G11 gene located in the major histocompatibility complex encodes a novel nuclear serine/threonine protein kinase. J. Biol., Chem., 47, 30954-30960.
11. Gitelman, S.E., Bristow, J. and Miller, W.L. (1992) Mechanism and consequences of the duplication of the human C4/P45Oc21/gene X locus. Mol. Cell. Biol., 12, 2124-2134; 3313.
12. Matsumoto, K., Ishihara, N., Ando, A., Inoko, H. and Ikemura, T. (1992) Extracellular matrix protein tenascin-like gene found in human MHC class III region. Immunogenetics, 36, 400-403.
13. Bristow, J., Tee, M.K., Gitelman, S.E., Mellon, S.H. and Miller, W.L. (1993) Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J. Cell Biol., 122, 265-278.
14. Yang, Z., Mendoza, A.R., Welch, T.R., Zipf, W.B. and Yu, C.Y. (1999) Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). J. Biol., Chem., 274, 12147-12156.
15. Blanchong, C.A., Zhou, B., Rupert, K.L., Chung, E.K., Jones, K.N., Sotos, J.F., Zipf, W.B., Rennebohm, R.M. and Yu, C.Y. (2000) Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians: the load of RCCX genetic diversity on major histocompatibility complex-associated disease. J. Exp. Med., 191, 2183-2196.
16. Koppens, P.F.J., Hoogenboezem, T., Halley, D.J.J., Barendse, C.A.M., Oostenbrink, A.J. and Degenhart, H.J. (1992) Family studies of the steroid 21-hydroxylase and complement C4 genes define 11 haplotypes in classical congenital adrenal hyperplasia in The Netherlands. Eur. J. Pediatr., 151, 885-892.
17. Donohoue, P.A., Van Dop, C., Jospe, N. and Migeon, C.J. (1986) Congenital adrenal hyperplasia: molecular mechanisms resulting in 21-hydroxylase deficiency. Acta Endocrinol., 113 (Suppl. 279), 315-320.
18. Schneider, P.M., Carroll, M.C., Alper, C.A., Rittner, C., Whitehead, A.S., Yunis, E.J. and Colten, H.R. (1986) Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J. Clin. Invest., 78, 650-657.
19. Higashi, Y, Tanae, A., Inoue, H. and Fujii-Kuriyama, Y. (1988) Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: implications for steroid 21-hydroxylase deficiency. Am. J. Hum. Genet., 42, 17-25.
20. White, P.C., Vitek, A., Dupont, B. and New, M.I. (1988) Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc. Natl Acad. Sci. USA, 85, 4436-4440.
21. Morel, Y., André, J., Uring-Lambert, B., Hauptmann, G., Bétuel, H., Tossi, M., Forest, M.G., David, M., Bertrand, J. and Miller, W.L. (1989) Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia. J. Clin. Invest., 83, 527-536.
22. Schneider, P.M. (1990). C4 DNA RFLP reference typing report. Compl. Inflamm., 7, 218-224.
23. Donohoue, P.A., Guethlein, L., Collins, M.M., Van Dop, C., Migeon, C.J., Bias, W.B. and Schmeckpeper, B.J. (1995) The HLA-A3,Cw6,B47,DR7 extended haplotypes in salt losing 21-hydroxylase deficiency and in the Old Order Amish: identical class I antigens and class II alleles with at least two crossover sites in the class III region. Tissue Antigens, 46, 163-172.
24. Helmberg, A., Tabarelli, M., Fuchs, M.A., Keller, E., Dobler, G., Schnegg, I., Knorr, D., Albert, E. and Kofler, R. (1992) Identification of molecular defects causing congenital adrenal hyperplasia by cloning and differential hybridization of polymerase chain reaction-amplified 21-hydroxylase (CYP21) genes. DNA Cell Biol., 11, 359-368.
25. Levo, A. and Partanen, J. (1997) Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles. Hum. Genet., 99, 488-497.
26. Koppens, P.F.J., Hoogenboezem, T. and Degenhart, H.J.(2000) CYP21 and CYP21P variability in steroid 21-hydroxylase deficiency patients and in the general population in The Netherlands. Eur. J. Hum. Genet., 8, 827-836.
27. Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O. and Fujii-Kuriyama, Y. (1986) Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc. Natl Acad. Sci. USA, 83, 2841-2845.
28. Rumsby, G., Carroll, M.C., Porter, R.R., Grant, D.B. and Hjelm, M. (1986) Deletion of the steroid 21-hydroxylase and complement C4 genes in congenital adrenal hyperplasia. J. Med. Genet., 23, 204-209.
29. Chu, X., Braun-Heimer, L., Rittner, C. and Schneider, P.M. (1992) Identification of the recombination site within the steroid 21-hydroxylase gene (CYP21) of the HLA-B47,DR7 haplotype. Exp. Clin. Immunogenet., 9, 80-85.
30. Lee, H.H., Chang, J.G., Tsai, C.H., Tsai, F.J., Chao, H.T. and Chung, B.C. (2000) Analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency. Clin. Chem., 46, 606-611.
31. Sinnott, P.J., Collier, S., Costigan, C., Dyer, P.A., Harris, R. and Strachan, T. (1990) Genesis by meiotic unequal crossover of a de novo deletion that contributes to steroid 21-hydroxylase deficiency. Proc. Natl Acad. Sci. USA, 87, 2107-2111.
32. I'Allemand, D., Tardy, V, Grüters, A., Schnabel, D., Krude, H. and Morel, Y. (2000) How a patient homozygous for a 30-kb deletion of the C4-CYP21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. J. Clin. Endocr. Metab., 85, 4562-4567.
33. Burch, G.H., Gong, Y., Liu, W, Dettman, R.W, Curry, C.J., Smith, L., Miller, W.L. and Bristow, J. (1997) Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat. Genet., 17, 104-108.
34. Schalkwijk, J., Zweers, M.C., Steijlen, P.M., Dean, W.B., Taylor, G., van Vlijmen, I.M., van Haren, B., Miller, W.L. and Bristow, J. (2001) A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N. Engl. J. Med., 345, 1167-1175.
35. Killeen, A.A., Sane, K.S. and Orr, H.T. (1991) Molecular and endocrine characterization of a mutation involving a recombination between the steroid 21-hydroxylase functional gene and pseudogene. J. Steroid Biochem. Mol. Biol., 38, 677-686.
36. Rupert, K.L., Rennebohm, R.M. and Yu, C.Y. (1999) An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis. Exp. Clin. Immunogenet., 16, 81-97.
37. Barlow, K.(2000) EMBL/GenBank/DDBJ accession no. AL049547.
38. Rowen, L., Dankers, C., Baskin, D., Faust, J., Loretz, C., Abeam, M.E., Banta, A., Schwartzell, S., Smith, T.M., Spies, T. and Hood, L. (1999) Sequnence determination of 300 kilobases of the human class III MHC locus. EMBL/GenBank/DDBJ accession no. AF019413.
39. Rowen, L., Dankers, C., Baskin, D., Faust, J., Loretz, C., Ahearn, M.E., Banta, A., Schwartzell, S., Smith, T.M., Spies, T. and Hood, L. (1999) Sequence determination of 300 kilobases of the human class III MHC locus. EMBL/GenBank/DDBJ accession no. U89337.
40. Yu, C.Y. (1991) The complete exon-intron structure of a human complement component C4A gene. DNA sequences, polymorphism, and linkage to the 21-hydroxylase locus. J. Immunol., 146, 1057-1066.
41. Dawkins, R.L., Martin, E., Kay, P.H., Garlepp, M.J., Wilton, A.N. and Stuckey, M.S. (1987) Heterogeneity of steroid 21-hydroxylase genes in classical congenital adrenal hyperplasia. J. Immunogenet., 14, 89-98.
42. Bachega, T.A.S.S., Billerbeck, A.E.C., Madureira, G., Arnhold, I.J.P., Medeiros, M.A., Marcondes, J.A.M., Longui, C.A., Nicolau, W, Bloise, W and Mendonça, B.B. (1999) Low frequency of CYP21B deletions in Brazilian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum. Hered., 49, 9-14.
43. Linder, A. (1960) Statistische Methoden, 3. Auflage. Birkhäuser Verlag, Basel-Stuttgart, pp. 286-287.
44. Collier, S., Tassabehji, M., Sinnott, P.J. and Strachan, T. (1993) A de novo pathological point mutation at the 21-hydroxylase locus: implications for gene conversion in the human genome. Nat. Genet., 3, 260-265; 4, 101.
45. Tajima, T., Fujieda, K. and Fujii-Kuriyama, Y. (1993) De novo mutation causes steroid 21-hydroxylase deficiency in one family of HLA-identical affected and unaffected siblings. J. Clin. Endocr. Metab., 77, 86-89.
46. Ordoñez-Sánchez, M., Ramírez-Jiménez, S., López-Gutierrez, A.U, Riba, L., Gamboa-Cardiel, S., Cerillo-Hinojosa, M., Altamirano-Bustamante, N., Calzada-León, R., Robles-Valdés, C., Mendoza-Morfin, F. and Tusié-Luna, M.T. (1998) Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: identification of possible new mutations and high prevalence of apparent germ-line mutations. Hum. Genet, 102, 170-177.
47. Tusié-Luna, M.T. and White, P.C. (1995) Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc. Natl Acad. Sci. USA, 92, 10796-10800.
48. Belt, K.T., Carroll, M.C. and Porter, R.R. (1984) The structural basis of the multiple forms of human complement component C4. Cell, 36, 907-914.